The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr Kailash Shantilal Choudhari
AKSHOPTFBR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.5 pts less than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Dr. Kailash Shantilal Choudhari, Promoter and Director of Aksh Optifibre, sold 2,02,500 equity shares (0.12% of paid-up capital) through open market on December 2 and 3, 2025. His individual holding reduced from 47,06,392 shares (2.89%) to 45,03,892 shares (2.77%). The promoter group, including PACs such as Rohan Rashi Family Trust, Mrs. Mona Kailash Choudhari, and others, collectively holds 5.71% of the company. The disclosure was filed under SEBI Takeover Regulations and the company's total share capital remains unchanged at ₹81.34 crore.
This is a small open-market sale by one promoter (0.12% of equity), unlikely to materially impact share price or promoter control. The promoter group continues to hold over 5.7%, suggesting no significant change in ownership structure.